FDA Investigator

Sara H Gabel

Latest inspection on record: Chatsworth, United States, April 2026 · records back to 2022

Human DrugsAnimal Drugs & Feeds

FDA inspection record · Last updated July 12, 2026

Overview

  • 27 inspections across 27 sites are on record.
  • 36 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-03.

At a glance

Inspections

27

Sites

27

Observations

36

Career since

Apr 2022

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
kdc/one Chatsworth, Inc.3 Apr 2026Human DrugsOn file
Pacira Pharmaceuticals, Inc.25 Mar 2026Human DrugsOn file
Nissan Chemical Corporation21 Nov 2025Human DrugsOn file
Ajinomoto Co., Inc.14 Nov 2025Human DrugsOn file
Environmental Technical Laboratory, Ltd.7 Nov 2025Human Drugs

Sites inspected

kdc/one Chatsworth, Inc.Chatsworth, United States1 insp.
Pacira Pharmaceuticals, Inc.San Diego, United States1 insp.
Nissan Chemical CorporationSanyo-Onoda, Japan1 insp.
Ajinomoto Co., Inc.Yokkaichi, Japan1 insp.
Environmental Technical Laboratory, Ltd.Adachi, Japan1 insp.

Co-investigators

Investigators who share inspections with this person.

Gloria E Andia3 shared
Alexandra A Cole2 shared
Ana-Maria A Plapcianu1 shared
Homero W Aguilar1 shared

Full investigator report

Get the verbatim findings behind Sara H Gabel's 36 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators